Jeffrey S. Weber, MD, PhD, deputy director of NYU Langone Health’s Perlmutter Cancer Center; Laura and Isaac Perlmutter Professor of Oncology in the Department of Medicine at NYU Grossman School of Medicine; and the 2016 Giant of Cancer Care® in Melanoma, discusses emerging therapies in melanoma.
Archive | Video Reports
Dr. Weber on Emerging Therapies in Melanoma
Posted in Melanoma News, Health Professionals, Video Reports
Dr. Johnson on the Limitations of Biomarkers in Melanoma
Douglas B. Johnson, MD, MSCI, assistant professor of medicine, Vanderbilt University Medical Center, clinical director, Melanoma Research Program, Vanderbilt-Ingram Cancer Center, discusses the limitations of biomarkers in melanoma.
Posted in Melanoma News, Health Professionals, Video Reports
Dr. Chandra on the Incidence of Targetable Mutations in Melanoma
Sunandana Chandra, MD, MS, assistant professor of medicine, Division of Hematology and Oncology, Northwestern University Feinberg School of Medicine, discusses the incidence of targetable mutations in melanoma.
Posted in Melanoma News, Health Professionals, Video Reports
Dr. Shapiro on the Utility of Complete Lymph Node Dissection in Melanoma
David R. Gandara, MD, director, Thoracic Oncology Program, professor, senior advisor to director, University of California Davis Comprehensive Cancer Center, and a 2017 Giant of Cancer Care® in Lung Cancer, discusses measuring tumor mutational burden (TMB) in patients with non–small cell lung cancer (NSCLC) who received prior immunotherapy.
Posted in Melanoma News, Health Professionals, Video Reports
